Clinical Trial Update: Apimostinel + Automated Neurocognitive Training for Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for depression evaluating Apimostinel in combination with Automated Neurocognitive Training; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Apimostinel (apimostinel)

Snippet

Sponsor: Rebecca Price | Conditions: Depression | Phase 2 | Status: RECRUITING